Hadi Karimzadeh

1.1k total citations
53 papers, 720 citations indexed

About

Hadi Karimzadeh is a scholar working on Rheumatology, Epidemiology and Hepatology. According to data from OpenAlex, Hadi Karimzadeh has authored 53 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 17 papers in Epidemiology and 15 papers in Hepatology. Recurrent topics in Hadi Karimzadeh's work include Hepatitis B Virus Studies (13 papers), Systemic Lupus Erythematosus Research (13 papers) and Hepatitis C virus research (13 papers). Hadi Karimzadeh is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Systemic Lupus Erythematosus Research (13 papers) and Hepatitis C virus research (13 papers). Hadi Karimzadeh collaborates with scholars based in Iran, Germany and France. Hadi Karimzadeh's co-authors include Michael Roggendorf, Mansoor Karimifar, Mohammad Arash Ramezani, Mansour Salesi, Michel Bazinet, Andrew Vaillant, Hrvoje Mijočević, Adalbert Krawczyk, Lilia Cojuhari and Valentin Cebotarescu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Hadi Karimzadeh

51 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadi Karimzadeh Iran 15 320 267 162 135 97 53 720
Serena Ludovisi Italy 14 217 0.7× 265 1.0× 74 0.5× 327 2.4× 334 3.4× 20 964
Shadi Hamdeh United States 10 252 0.8× 100 0.4× 70 0.4× 55 0.4× 223 2.3× 27 619
Cristóvão Luís Pitangueira Mangueira Brazil 12 117 0.4× 52 0.2× 107 0.7× 96 0.7× 112 1.2× 48 475
Qiang Yan China 16 180 0.6× 181 0.7× 23 0.1× 107 0.8× 116 1.2× 41 638
Antonio Tarantino Italy 18 245 0.8× 233 0.9× 84 0.5× 57 0.4× 70 0.7× 36 1.1k
David Rowbotham New Zealand 16 330 1.0× 115 0.4× 50 0.3× 78 0.6× 61 0.6× 58 773
Sophia Horster Germany 12 223 0.7× 114 0.4× 32 0.2× 92 0.7× 44 0.5× 37 623
Giammarco Mocci Italy 14 358 1.1× 102 0.4× 59 0.4× 190 1.4× 115 1.2× 38 714
Tamsin Cargill United Kingdom 18 421 1.3× 112 0.4× 379 2.3× 123 0.9× 90 0.9× 33 898
Uzma Shah United States 16 366 1.1× 251 0.9× 34 0.2× 83 0.6× 49 0.5× 40 905

Countries citing papers authored by Hadi Karimzadeh

Since Specialization
Citations

This map shows the geographic impact of Hadi Karimzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadi Karimzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadi Karimzadeh more than expected).

Fields of papers citing papers by Hadi Karimzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadi Karimzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadi Karimzadeh. The network helps show where Hadi Karimzadeh may publish in the future.

Co-authorship network of co-authors of Hadi Karimzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Hadi Karimzadeh. A scholar is included among the top collaborators of Hadi Karimzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadi Karimzadeh. Hadi Karimzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karimzadeh, Hadi, Julia Thorn‐Seshold, Elena Winheim, et al.. (2024). Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nature Communications. 15(1). 1696–1696. 15 indexed citations
2.
Gharibdoost, Farhad, Mansour Salesi, Maryam Sahebari, et al.. (2021). Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study. Advances in Therapy. 38(2). 1290–1300. 4 indexed citations
3.
Salehi, Amin, et al.. (2019). Designing and Manufacture of Training Simulator for Injecting and Fluid Removing of Knee Joint. SHILAP Revista de lepidopterología. 8(1). 28–28.
4.
Mijočević, Hrvoje, Hadi Karimzadeh, Mamun Al‐Mahtab, et al.. (2018). Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139‐Ca have no influence on treatment outcome and its detection by diagnostic assays. Journal of Viral Hepatitis. 26(4). 485–495. 2 indexed citations
5.
Bazinet, Michel, Victor Pântea, Valentin Cebotarescu, et al.. (2017). Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. ˜The œLancet. Gastroenterology & hepatology. 2(12). 877–889. 187 indexed citations
6.
Mijočević, Hrvoje, Hadi Karimzadeh, Michel Bazinet, et al.. (2017). Absence of mutations in the HBsAg “a” determinant during REP 2139 therapy validates serum HBsAg reductions observed in the REP 102 protocol. Journal of Hepatology. 66(1). S257–S257. 1 indexed citations
7.
8.
Karimzadeh, Hadi, et al.. (2016). The Relation of Vitamin D Deficiency and Activity of Systematic Lupus Erythematosis. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Kianersi, Farzan, Zahra Mohammadi, Heshmatollah Ghanbari, et al.. (2014). Clinical Patterns of Uveitis in an Iranian Tertiary Eye-care Center. Ocular Immunology and Inflammation. 23(4). 278–282. 38 indexed citations
10.
Montazeri, Ghodratollah, Hadi Karimzadeh, Reza Malekzadeh, et al.. (2014). Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy.. PubMed. 17(9). 638–45. 2 indexed citations
11.
Salesi, Mansour, et al.. (2014). The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis. SHILAP Revista de lepidopterología. 10 indexed citations
12.
Karimifar, Mansoor, et al.. (2012). Clinical and Laboratory Signs among Systemic Lupus Erythematosus Patients in Isfahan. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Farajzadegan, Ziba, et al.. (2012). Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate. Journal of Research in Pharmacy Practice. 1(2). 72–72. 10 indexed citations
14.
Salesi, Mansour, et al.. (2010). Disease Activity Index and its Association with Serum Concentration of Anti-cyclic Citrullinated Peptide 1 (Anti-CCP1) in Patients with Rheumatoid Arthritis. Razi Journal of Medical Sciences. 17(74). 15–21. 4 indexed citations
15.
Ramezani, Mohammad Arash, et al.. (2010). The Relationship of Opium Addiction with Coronary Artery Disease. SHILAP Revista de lepidopterología. 20 indexed citations
16.
Salehi, Mansoor, et al.. (2009). Distribution of HLA-B*27 alleles in patients with ankylosing spondylitis in Iran.. PubMed. 6(1). 49–54. 10 indexed citations
17.
Malekzadeh, Reza, et al.. (2008). Identification of HBV surface Ag variants in patients with hepatitis before and after immunization.. 12(4). 229–234. 2 indexed citations
18.
Karimzadeh, Hadi, et al.. (2008). Definition of a population‐specific dual energy X‐ray absorptiometry reference standard in Isfahani women. International Journal of Rheumatic Diseases. 11(4). 400–406. 2 indexed citations
19.
Andalib, Alireza, et al.. (2005). A FLOWCYTOMETRY STUDY OF CD55 AND CD59 EXPRESSION ON ERYTHROCYTES IN RHEUMATOID ARTHRITIS PATIENTS. 2(2). 91–96. 4 indexed citations
20.
Karimzadeh, Hadi, et al.. (2002). CHLOROQUINE VS STEROID INJECTION IN MANAGEMENT OF PRIMARY KNEE OSTEOARTHRITIS: A DOUBLE BLINDED RANDOMIZED CLINICAL TRIAL. SHILAP Revista de lepidopterología. 7(1). 57–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serena Ludovisi Breakdown of academic impact, for papers by Shadi Hamdeh Breakdown of academic impact, for papers by Cristóvão Luís Pitangueira Mangueira Breakdown of academic impact, for papers by Qiang Yan Breakdown of academic impact, for papers by Antonio Tarantino Breakdown of academic impact, for papers by David Rowbotham Breakdown of academic impact, for papers by Sophia Horster Breakdown of academic impact, for papers by Giammarco Mocci Breakdown of academic impact, for papers by Tamsin Cargill Breakdown of academic impact, for papers by Uzma Shah
Rankless by CCL
2026